Ultragenyx Pharmaceutical, Inc. (RARE)
24.81
+0.29
(+1.18%)
USD |
NASDAQ |
Apr 17, 16:00
24.82
+0.01
(+0.04%)
After-Hours: 20:00
Ultragenyx Pharmaceutical EPS Diluted (Quarterly) : -1.291 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Xencor, Inc. | -0.0892 |
| REGENXBIO, Inc. | -1.298 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -129.00M |
| Revenue (Quarterly) | 207.00M |
| Total Expenses (Quarterly) | 336.00M |
| Enterprise Value | 2.963B |
| Gross Profit Margin (Quarterly) | 81.75% |
| Profit Margin (Quarterly) | -62.32% |
| Earnings Yield | -23.52% |
| Normalized Earnings Yield | -23.54 |